BXCL501: Clinical Trials

5 trials of BXCL501, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 12Completed 2

Follow BXCL501: new trials by email Literature Review of BXCL501 trials Research Report on BXCL501

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BXCL501 After Stress to Increase Recovery Success
BXCL501 (dexmedetomidine HCl), Placebo - Acute Stress Reaction, Acute Stress Disorder
Phase 2RecruitingUniversity of North Carolina, Chapel Hill1002026-02-232026-04-14
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
BXCL501, Placebo film - Agitation, Dementia
Phase 2TerminatedBioXcel Therapeutics Inc52022-02-082026-08-11
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
BXCL501, Placebo film - Agitation, Delirium
Phase 2WithdrawnBioXcel Therapeutics Inc2021-02-232026-08-11
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Dexmedetomidine, Placebo - Opioid Withdrawal
Phase 1 / Phase 2CompletedBioXcel Therapeutics Inc2252020-06-092026-08-11
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
Sublingual film containing Dexmedetomidine, Sublingual Placebo Film - Agitation,Psychomotor, Dementia
Phase 1 / Phase 2CompletedBioXcel Therapeutics Inc1002019-12-272026-08-11

Conditions studied

Psychomotor Agitation (4)  ·  Dementia (2)  ·  Delirium (1)  ·  Morphine Dependence (1)  ·  Opioid-Related Disorders (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Stress Disorders, Traumatic, Acute (1)

Sponsors

BioXcel Therapeutics Inc (4)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (5)

Top investigators

BioXcel MM, MD (4)  ·  Samuel McLean, MD (1)  ·  Stacey House, MD (1)

Results publications

PMID 36280451